|
Bicalutamide Clinical Trials
8 actively recruiting trials across 6 locations
▲ +2 trials since May 2026
Also known as: Bicalutamide Teva, Casodex, Cassotide, Cosudex, ICI 176,334 +3 more
Pipeline
Phase 1: 1Phase 2: 4Phase 3: 2Phase 1/2: 1
Top Sponsors
- University of Wisconsin, Madison1
- Universitaire Ziekenhuizen KU Leuven1
- SWOG Cancer Research Network1
- Icahn School of Medicine at Mount Sinai1
- Emory University1
Indications
- Cancer8
- Stage IVA Prostate Cancer AJCC v83
- Stage IVB Prostate Cancer AJCC v82
- Stage IV Prostate Cancer AJCC v82
- Breast Cancer2
Other2 trials
Gilbert, Arizona1 trial
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Banner MD Anderson Cancer Center
Phase 3
Tucson, Arizona1 trial
A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer
University of Arizona Cancer Center - Prevention Research Clinic
Phase 1
Duarte, California1 trial
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
City of Hope Medical Center
Phase 2
Miami, Florida1 trial
Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
Miami Cancer Institute at Baptist Health, Inc.
Phase 2
Atlanta, Georgia1 trial
REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial
Emory Proton Therapy Center
Phase 3
New York, New York1 trial
Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
Mount Sinai Beth Israel
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.